Audentes Therapeutics, Inc. Business Combination, Contingent Consideration, Liability
Audentes Therapeutics, Inc. had Business Combination, Contingent Consideration, Liability of $2.46 million as of 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2019-11-07
- 2019-09-30: Business Combination, Contingent Consideration, Liability $2.46M.
- 2019-06-30: Business Combination, Contingent Consideration, Liability $2.40M.
- 2019-03-31: Business Combination, Contingent Consideration, Liability $2.32M.
- 2018-12-31: Business Combination, Contingent Consideration, Liability $2.35M.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2019-09-30 | $2.46M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $2.40M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $2.32M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $2.35M 10-Q · filed 2019-11-07 |
| 2018-09-30 | $2.32M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $2.30M 10-Q · filed 2018-08-07 |
| 2017-12-31 | $4.64M 10-Q · filed 2018-11-07 |
| 2015-08-31 | $10.00M 10-Q · filed 2019-11-07 |